<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01350674</url>
  </required_header>
  <id_info>
    <org_study_id>B07620109427</org_study_id>
    <secondary_id>AK/10-10-3949/67</secondary_id>
    <nct_id>NCT01350674</nct_id>
  </id_info>
  <brief_title>Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes</brief_title>
  <official_title>Role of EBUS-TBNA (Endobronchial Ultrasound Transbronchial Needle Aspiration- in Diagnosing Tuberculosis in Mediastinal and/or Hilar Lymph Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational prospective study. Role of EBUS-TBNA (endobronchial ultrasound
      transbronchial needle aspiration) is evaluated to diagnose tuberculosis in mediastinal and/or
      hilar lymph nodes.

      The investigators analyse the specificity and sensibility of this technique to diagnose
      tuberculosis in mediastinal and/or hilar lymph nodes.

      Patients with mediastinal and/or hilar lymph nodes on X-ray or CT thorax where a tuberculosis
      is the most probable cause and who have no parenchymal lesions suspected for tuberculosis and
      without other lymph nodes that are more easily accessible or palpable will be included in
      this study.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The ratio of tuberculosis in mediastinal lymph nodes</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>EBUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing EBUS</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS-TBNA</intervention_name>
    <description>endobronchial ultrasound transbronchial needle aspiration</description>
    <arm_group_label>EBUS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with enlarged mediastinal and/or hilar lymph nodes on chest CT highly
             suspicious of tuberculosis (suggestive clinical history, suggestive echographic
             findings ...) without pulmonary lesions suspicious for tuberculosis or in whom the
             first evaluation with sputum examination, classical bronchoscopy, induced sputum
             didn't result in any diagnosis.

          -  patients aged 18 years or older

          -  patients need to sign the consent form after reading the information form

        Exclusion Criteria:

          -  synchronic pulmonary lesions suspicious for tuberculosis or already proven
             tuberculosis by microscopic exam, PCR-technique and/or culture

          -  other affected ganglionary sites more easily accessible (cervical, supraclavicular,
             axillary ... region)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inge M Muylle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU St. Pierre Brussels</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU St. Pierre; pulmonology department</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mediastinal tuberculosis</keyword>
  <keyword>endoscopy</keyword>
  <keyword>EBUS</keyword>
  <keyword>tuberculous lymphadenopathy</keyword>
  <keyword>endobronchial ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

